Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?
Ulivi P, Delmonte A, Chiadini E, Calistri D, Papi M, Mariotti M, Verlicchi A, Ragazzini A, Capelli L, Gamboni A, Puccetti M, Dubini A, Burgio MA, Casanova C, Crinò L, Amadori D, Dazzi C. Ulivi P, et al. Among authors: verlicchi a. Int J Mol Sci. 2014 Dec 31;16(1):747-57. doi: 10.3390/ijms16010747. Int J Mol Sci. 2014. PMID: 25561229 Free PMC article.
Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.
Ulivi P, Chiadini E, Dazzi C, Dubini A, Costantini M, Medri L, Puccetti M, Capelli L, Calistri D, Verlicchi A, Gamboni A, Papi M, Mariotti M, De Luigi N, Scarpi E, Bravaccini S, Turolla GM, Amadori D, Crinò L, Delmonte A. Ulivi P, et al. Among authors: verlicchi a. Clin Lung Cancer. 2016 Sep;17(5):384-390. doi: 10.1016/j.cllc.2015.11.004. Epub 2015 Dec 1. Clin Lung Cancer. 2016. PMID: 26712101
Targeting RET-rearranged non-small-cell lung cancer: future prospects.
Bronte G, Ulivi P, Verlicchi A, Cravero P, Delmonte A, Crinò L. Bronte G, et al. Among authors: verlicchi a. Lung Cancer (Auckl). 2019 Mar 20;10:27-36. doi: 10.2147/LCTT.S192830. eCollection 2019. Lung Cancer (Auckl). 2019. PMID: 30962732 Free PMC article. Review.
New generation anaplastic lymphoma kinase inhibitors.
Delmonte A, Burgio MA, Verlicchi A, Bronte G, Cravero P, Ulivi P, Martinelli G, Crinò L. Delmonte A, et al. Among authors: verlicchi a. Transl Lung Cancer Res. 2019 Nov;8(Suppl 3):S280-S289. doi: 10.21037/tlcr.2019.09.14. Transl Lung Cancer Res. 2019. PMID: 31857951 Free PMC article. Review.
Case Report: Circulating Myeloid-Derived Suppressive-Like Cells and Exhausted Immune Cells in Non-Small Cell Lung Cancer Patients Treated With Three Immune Checkpoint Inhibitors.
Bronte G, Verlicchi A, De Matteis S, Rossi A, Affatato A, Sullo FG, Gianni C, Canale M, Burgio MA, Delmonte A, Milella M, Crinò L. Bronte G, et al. Among authors: verlicchi a. Front Immunol. 2021 May 27;12:672219. doi: 10.3389/fimmu.2021.672219. eCollection 2021. Front Immunol. 2021. PMID: 34122429 Free PMC article.
34 results